Join the Pneumonia group to help and get support from people like you.
Pneumonia News (Page 2)
Related terms: Bronchopneumonia, Community-acquired pneumonia, Acute Pneumonia
Inhaled Amikacin Reduces Ventilatory-Associated Pneumonia
MONDAY, Oct. 30, 2023 – For critically ill patients undergoing mechanical ventilation for at least three days, a three-day course of inhaled amikacin reduces the subsequent burden of...
Olympian Mary Lou Retton Suffers Setback in Battle With Rare Form of Pneumonia
THURSDAY, Oct. 19, 2023 – Former Olympic gymnast Mary Lou Retton has suffered a "scary setback" as she fights a rare type of pneumonia while in the intensive care unit of a hospital, her family said...
Olympic Legend Mary Lou Retton Battling Rare Form of Pneumonia
WEDNESDAY, Oct. 11, 2023 – Olympic icon Mary Lou Retton – the first American woman to win the all-around gold medal in women's gymnastics – is in intensive care with a rare type of pneumonia and...
Paratek Pharmaceuticals Announces FDA Approval of Nuzyra (omadacycline) Oral Only Dosing Regimen for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
BOSTON, June 01, 2021 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel...
FDA Approves Fetroja (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE) September 28, 2020 --Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that the U.S. Food and Drug Administration (FDA) has approved a sup...
FDA Approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
KENILWORTH, N.J.--(BUSINESS WIRE) June 5, 2020 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Baxdela (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
MORRISTOWN, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) – Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...
FDA Approves Xenleta (lefamulin) to Treat Community-Acquired Bacterial Pneumonia (CABP)
DUBLIN, Ireland, Aug. 19, 2019 (GLOBE NEWSWIRE) – Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective...
FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...
FDA Approves Avycaz (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
DUBLIN, Feb. 1, 2018 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Allergan's...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones:...
Allergan Receives FDA Approval of Teflaro (ceftaroline fosamil) for Pediatric Patients
DUBLIN, May 31, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's...
Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)
DUBLIN, IRELAND – (Marketwired) – 05/09/16 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA)...
FDA Approves Vibativ for Hospitalized Patients with Bacterial Pneumonia
June 21, 2013 – The U.S. Food and Drug Administration today expanded the approved use of the antibiotic Vibativ (telavancin) to treat patients with hospital-acquired and ventilator-associated...
FDA Approves Teflaro for Bacterial Infections
SILVER SPRING, Md., Oct. 29 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community...
Further information
Related drug support groups
amoxicillin, doxycycline, metronidazole, clindamycin, azithromycin, Bactrim, Cipro, ciprofloxacin, Zithromax, view more... Flagyl, Levaquin, Augmentin, erythromycin, levofloxacin, clarithromycin, amoxicillin / clavulanate, cefdinir, sulfamethoxazole / trimethoprim, vancomycin, Bactrim DS, tetracycline, Rocephin